(Medical Xpress)—A Purdue University scientist is studying the way cells repair damaged DNA in the hopes of making cancer cells more susceptible to treatment and normal tissue better able to withstand it.
Jan 16, 2013
0
0
Spanish researchers have traced the bacterial microbiota map in breast milk, which is the main source of nourishment for newborns. The study has revealed a larger microbial diversity than originally thought: more than 700 ...
Jan 4, 2013
0
1
(Medical Xpress)—The holidays are a time to consume—food, gifts, and spirits. Here are a few alcohol-related story ideas from The Methodist Hospital. Because alcohol's effects on human physiology are complex, advice about ...
Dec 20, 2012
1
0
The DNA mutations that accumulate over time as women age are not the sole contributor to the higher frequency of breast cancer in women over 50, Mark LaBarge, PhD, a researcher at Lawrence Berkeley National Laboratory (LBNL) ...
Dec 17, 2012
0
0
Johns Hopkins scientists have found a surprising mechanism that gives male sex hormones like testosterone control over the gender-specific absence or presence of mammary gland nerves that sense the amount of milk available ...
Dec 6, 2012
0
0
Scientists have discovered new types of early cells in mammary glands, uncovering clues to the origins of different breast cancers - and potential new drug targets, according to findings published in Breast Cancer Research.
Oct 29, 2012
0
0
A protein that is necessary for lactation in mammals inhibits the critical cellular transition that is an early indicator of breast cancer and metastasis, according to research conducted at the University at Buffalo and Princeton ...
Oct 24, 2012
0
0
The hormone prolactin is produced by the pituitary gland in the brain and then travels via the bloodstream to cells throughout the body, where it exerts multiple reproductive and metabolic effects, most notably on the breast ...
Oct 1, 2012
0
0
Death plays a big role in keeping things alive. Consider the tightly orchestrated suicide of cells—a phenomenon essential to everything from shaping an embryo to keeping it free of cancer later in life. When cells refuse ...
Sep 24, 2012
0
0
Inhibitors of indoleamine 2,3-dioxygenase (IDO) are being assessed in clinical trials as a potential treatment for recurrent or refractory solid tumors. Clear genetic rationale for these trials, together with evidence that ...
Jul 19, 2012
0
0
